Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
6.29
-0.37 (-5.56%)
At close: Aug 15, 2025, 4:00 PM
6.59
+0.30 (4.77%)
After-hours: Aug 15, 2025, 7:42 PM EDT
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $42.37 million as of August 15, 2025. Its market cap has decreased by -80.35% in one year.
Market Cap
42.37M
Enterprise Value
-13.67M
1-Year Change
-80.35%
Ranking
Category
Stock Price
$6.29
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $42.37M, a decrease of -96.05%. That is a compound annual growth rate of -46.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 44.86M | -36.64% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 588.74B |
| Johnson & Johnson | 419.03B |
| AbbVie | 355.31B |
| UnitedHealth Group | 244.59B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.34B |
| Novo Nordisk | 223.00B |